NDC 0173-0780 Lamictal Odt
Lamotrigine Kit - View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 0173 - Glaxosmithkline Llc
- 0173-0780 - Lamictal
Product Characteristics
ORANGE (C48331 - PEACH)
WHITE (C48325 - CREAM)
BLUE (C48333)
WHITE (C48325 - WHITE TO OFF-WHITE)
ROUND (C48348)
OVAL (C48345)
11 MM
12 MM
5 MM
8 MM
7 MM
9 MM
14 MM
LAMICTAL;100
LAMICTAL;150
LAMICTAL;200
LTG;2
GX;CL2
GX;CL5
LMT;25
LMT;50
1
CHERRY (C73375)
Product Packages
NDC Code 0173-0780-00
Package Description: 1 BLISTER PACK in 1 PACKAGE, COMBINATION / 1 KIT in 1 BLISTER PACK
Product Details
What is NDC 0173-0780?
What are the uses for Lamictal Odt?
Which are Lamictal Odt UNII Codes?
The UNII codes for the active ingredients in this product are:
- LAMOTRIGINE (UNII: U3H27498KS)
- LAMOTRIGINE (UNII: U3H27498KS) (Active Moiety)
Which are Lamictal Odt Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- LACTOSE, UNSPECIFIED FORM (UNII: J2B2A4N98G)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- POVIDONES (UNII: FZ989GH94E)
- SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)
- FD&C YELLOW NO. 6 (UNII: H77VEI93A8)
- FERRIC OXIDE YELLOW (UNII: EX438O2MRT)
- FD&C BLUE NO. 2 (UNII: L06K8R7DQK)
- CALCIUM CARBONATE (UNII: H0G9379FGK)
- HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED (UNII: 2165RE0K14)
- SACCHARIN SODIUM (UNII: SB8ZUX40TY)
- MAGNESIUM ALUMINUM SILICATE (UNII: 6M3P64V0NC)
- CROSPOVIDONE (15 MPA.S AT 5%) (UNII: 68401960MK)
- MANNITOL (UNII: 3OWL53L36A)
- SUCRALOSE (UNII: 96K6UQ3ZD4)
- ETHYLCELLULOSE (100 MPA.S) (UNII: 47MLB0F1MV)
What is the NDC to RxNorm Crosswalk for Lamictal Odt?
- RxCUI: 103968 - lamoTRIgine 100 MG Disintegrating Oral Tablet
- RxCUI: 103968 - lamotrigine 100 MG Disintegrating Oral Tablet
- RxCUI: 105018 - LaMICtal 100 MG Oral Tablet
- RxCUI: 105018 - lamotrigine 100 MG Oral Tablet [Lamictal]
- RxCUI: 105018 - Lamictal 100 MG Oral Tablet
* Please review the disclaimer below.
Patient Education
Lamotrigine
Lamotrigine extended-release (long-acting) tablets are used with other medications to treat certain types of seizures in patients who have epilepsy. All types of lamotrigine tablets (tablets, orally disintegrating tablets, and chewable tablets) other than the extended-release tablets are used alone or with other medications to treat seizures in people who have epilepsy or Lennox-Gastaut syndrome (a disorder that causes seizures and often causes developmental delays). All types of lamotrigine tablets other than the extended-release tablets are also used to increase the time between episodes of depression, mania (frenzied or abnormally excited mood), and other abnormal moods in patients with bipolar I disorder (manic-depressive disorder; a disease that causes episodes of depression, episodes of mania, and other abnormal moods). Lamotrigine has not been shown to be effective when people experience the actual episodes of depression or mania, so other medications must be used to help people recover from these episodes. Lamotrigine is in a class of medications called anticonvulsants. It works by decreasing abnormal electrical activity in the brain.
[Learn More]
* Please review the disclaimer below.
[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".